https://nova.newcastle.edu.au/vital/access/ /manager/Index ${session.getAttribute("locale")} 5 https://nova.newcastle.edu.au/vital/access/ /manager/Repository/uon:14762 Wed 11 Apr 2018 14:39:01 AEST ]]> https://nova.newcastle.edu.au/vital/access/ /manager/Repository/uon:26117 Wed 11 Apr 2018 13:45:35 AEST ]]> https://nova.newcastle.edu.au/vital/access/ /manager/Repository/uon:19505 Wed 11 Apr 2018 10:52:10 AEST ]]> https://nova.newcastle.edu.au/vital/access/ /manager/Repository/uon:15136 Wed 11 Apr 2018 09:13:41 AEST ]]> https://nova.newcastle.edu.au/vital/access/ /manager/Repository/uon:33908 Thu 27 Jan 2022 15:58:48 AEDT ]]> https://nova.newcastle.edu.au/vital/access/ /manager/Repository/uon:15360 Sat 24 Mar 2018 08:25:45 AEDT ]]> https://nova.newcastle.edu.au/vital/access/ /manager/Repository/uon:12306 2 = 79%). When the four trials by Boldt are excluded, the RR is 0.76 (95% CI 0.62 to 0.93). On average, PRP did not significantly reduce the total volume of RBC transfused (weighted mean difference [WMD] -0.69, 95%CI -1.93 to 0.56 units). Trials provided inadequate data regarding the impact of PRP on morbidity, mortality, and hospital length of stay. Trials were generally small and of poor methodological quality. Authors' conclusions: Although the results suggest that PRP is effective in reducing allogeneic RBC transfusion in adult patients undergoing elective surgery, there was considerable heterogeneity of treatment effects and the trials were of poor methodological quality. The available studies provided inadequate data for firm conclusions to be drawn regarding the impact of PRP on clinically important endpoints.]]> Sat 24 Mar 2018 08:11:35 AEDT ]]> https://nova.newcastle.edu.au/vital/access/ /manager/Repository/uon:10904 Sat 24 Mar 2018 08:07:43 AEDT ]]> https://nova.newcastle.edu.au/vital/access/ /manager/Repository/uon:17307 Sat 24 Mar 2018 08:01:48 AEDT ]]> https://nova.newcastle.edu.au/vital/access/ /manager/Repository/uon:20739 0.1). Males and females consuming green leafy vegetables 5-7 days/wk had 38% (P = 0.04) and 50% (P = 0.007) reduced odds of developing EC, respectively, compared with consumption ≤1 day/wk. A similar reduction in odds was observed with fruit consumption. Principal component factor analysis revealed 3 distinct dietary patterns. In females, high vs. low consumption of Pattern 1 (sorghum, green leafy vegetables, green legumes, fruits, meat) was inversely associated with EC development (OR = 0.54; 95% CI: 0.34-0.89), whereas for Pattern 2 (maize, wild greens-imifino, dry beans) the odds were elevated (OR = 1.67; 95% CI: 1.04-2.67). Compared with low adherence, high adherence to Pattern 3 (wheat-based products) reduced the odds by 35% for both sexes. This study provides further evidence on the role of diet in minimizing EC risk in this population.]]> Sat 24 Mar 2018 08:00:23 AEDT ]]> https://nova.newcastle.edu.au/vital/access/ /manager/Repository/uon:23698 Sat 24 Mar 2018 07:13:26 AEDT ]]> https://nova.newcastle.edu.au/vital/access/ /manager/Repository/uon:24595 14 g of tobacco per day were observed to have over 4-times the odds of developing OC (males OR = 4.36, 95% CI 2.24-8.48; females OR = 4.56, 95% CI 1.46-14.30), with pipe smoking showing the strongest effect. Similar trends were observed for the alcohol-related variables. The quantity of ethanol consumed was the most important factor in OC development rather than any individual type of alcoholic beverage, especially in smokers. Males and females consuming >53 g of ethanol per day had approximately 5-times greater odds in comparison to non-drinkers (males OR = 4.72, 95% CI 2.64-8.41; females OR = 5.24, 95% CI 3.34-8.23) and 8.5 greater odds in those who smoked >14 g tobacco daily. The attributable fractions for smoking and alcohol consumption were 58% and 48% respectively, 64% for both factors combined. Conclusion: Tobacco and alcohol use are major risk factors for OC development in this region. Impact: This study provides evidence for further reinforcement of cessation of smoking and alcohol consumption to curb OC development.]]> Fri 01 Apr 2022 09:30:03 AEDT ]]>